梅트로尼达的临床药理动力学:一个系统的审查和元分析
Iqra Shahzad1, Mohammed S Alasmari2, Ammara Zamir1
1Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan.
Antimicrobial agents and chemotherapy
|July 31, 2025
概括
通过曲线下的面积 (AUC) 测量的甲尼达 (MTZ) 药理动力学在不同患者群体之间存在显著差异. 这凸显了个性化剂量的必要性,以优化MTZ治疗和患者的治疗结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 药物代谢和药理动力学
背景情况:
- 甲尼达 (MTZ) 是广泛的处方,但其药理动力学可以因患者特定的生理和病理因素而改变.
- 了解这些药理动力学变异对于优化治疗疗效和安全至关重要.
- 个性化剂量策略对于有效的甲尼达治疗至关重要.
研究的目的:
- 在不同患者群体中,系统地审查和元分析甲尼达 (MTZ) 度-时间曲线 (AUC) 下的区域.
- 为提供MTZ药理动力学变异性的全面评估.
- 为MTZ治疗提供基于证据的临床决策提供信息.
主要方法:
- 在四个数据库 (PubMed,ScienceDirect,Cochrane Library,Google Scholar) 进行系统的文献搜索,直到2024年7月.
- 包括67项关于MTZ的药理动力学研究.
- 使用随机效应模型对度-时间曲线 (AUC) 下面面积的元分析以及对I2统计数据的异质性评估.
主要成果:
- 在不同患者群体中观察到度-时间曲线 (AUC) 下的甲尼达 (MTZ) 区域有显著差异.
- 在包括的研究中发现了大量的异质性,这表明MTZ药理动力学存在相当大的变化.
- 聚合的AUC值与95%的置信区间进行了比较和可视化,以说明人群特异性的差异.
结论:
- 分析证实了美特罗尼达 (MTZ) 药理动学的显著的人口间变异性,特别是药物总暴露率 (AUC).
- 这些发现强调了对美特罗尼达的个性化剂量方案的迫切需要.
- 量身定制的剂量方法对于提高临床实践中甲尼达治疗的安全性和疗效至关重要.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
299
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
299
Pharmacokinetics: Overview
7.2K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
7.2K
Factors Influencing Drug Absorption: Presystemic Elimination
347
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
347
Nonlinear Pharmacokinetics: Overview
562
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
562
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
126
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
126
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K


